Podcasts
Listen to the latest oncology news from international experts
The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
GI highlights from ESMO 2026: G-HOPE-001, SANO and more
In this week’s episode of VJOncology podcasts, we explore highlights in gastrointestinal (GI) cancer from the 2026 ESMO Annual Meeting and mark both gastric and pancreatic cancer awareness month. Join leading experts Filippo Pietrantonio of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Hiroya Taniguchi from Aichi Cancer Center Hospital, Aichi, Japan, Zev Wainberg of University of California, Los Angeles, CA, Lorenza Rimassa of Hunimed University, Milan, Italy, and David Tougeron of Poitiers University Hospital, Poitiers, France, to hear updates in GI cancer from the meeting. They discuss results from the SANO, RASolute 302, G-HOPE-001, KEYNOTE-975, PRABITAS, AZUR-1, EMERALD-3, FORTITUDE-101 and FORTITUDE-102 trials, as well as treatment strategies in gastric, pancreatic and rectal cancer.
This podcast is intended for healthcare professionals. VJOncology’s Gastrointestinal Cancer Channel is supported by a life sciences company (listed on the channel page), which has no influence over the content.
Date: 6th November 2026
